董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrew J. Miclot | 男 | Director | 70 | 12.57万美元 | 12.25 | 2026-03-19 |
| Joseph N. Forkey | 男 | Director, Chief Executive Officer, President and Treasurer | 58 | 110.66万美元 | 42.92 | 2026-03-19 |
| Buell G. Duncan | 男 | Director | 73 | 17.95万美元 | 5.25 | 2026-03-19 |
| Joseph P. Pellegrino, Jr. | 男 | Director | 61 | 18.20万美元 | 5.25 | 2026-03-19 |
| Peter H. Woodward | 男 | Chairman of the Board | 53 | 15.95万美元 | 46.97 | 2026-03-19 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Wayne M. Coll | 男 | Chief Financial Officer and Secretary | 62 | 48.71万美元 | 7.27 | 2026-03-19 |
| Joseph N. Forkey | 男 | Director, Chief Executive Officer, President and Treasurer | 58 | 110.66万美元 | 42.92 | 2026-03-19 |
| Joseph Traut | 男 | Chief Operating Officer | 54 | 未披露 | 未持股 | 2026-03-19 |
董事简历
中英对照 | 中文 | 英文- Andrew J. Miclot
-
Andrew J. Miclot于2016年3月2日被任命为Precision Optics Corporation, Inc.董事会成员。Miclot先生拥有超过35年的医疗设备供应商领导经验，并为Precision Optics Corporation, Inc.公司带来了丰富的全球行业知识。从2020年9月到2021年5月，Miclot先生担任Electromedical Products International，Inc.的总裁，该公司是一家治疗焦虑、失眠、抑郁和疼痛的医疗设备公司。Miclot先生于2017年10月至2019年1月担任WishBone Medical，Inc.的总裁兼副董事长兼董事，该公司是一家儿科骨科公司，致力于满足患有骨科疾病的儿童未满足的需求。他于2016年10月至2021年10月担任印第安纳大学校友会顾问委员会成员。2015年10月至2018年1月，Miclot先生担任Micro Machine Co.的总裁、首席执行官和董事，该公司是一家为骨科和脊柱行业提供医疗产品的供应商。在2013年5月至2014年9月加入Micro Machine公司之前，Miclot先生是医疗设备供应商MicroTechnologies公司的执行副总裁。Miclot先生于2009年6月至2013年3月担任ArtroCare公司总经理兼高级副总裁。2008年1月至2009年3月，Miclot先生担任Ascension Orthopedics，Inc.总裁、首席执行官和董事。2007年4月至2008年1月，他担任Orthofix，Inc.骨科全球业务部门的营销副总裁。1994年3月至2007年4月，他担任医疗设备供应商Symmetry医疗的高级副总裁，并在2004年12月至2007年4月纽约证券交易所上市后担任投资者关系官。Miclot先生拥有印第安纳大学的语音和听力学士学位和听力学硕士学位，以及1991年获得的Lake Forest管理研究生院的MBA学位。
Andrew J. Miclot has more than 35 years of leadership experience with medical device suppliers. From September 2020 to May 2021, Mr. Miclot was President of Electromedical Products International, Inc., a medical device company treating anxiety, insomnia, depression and pain. Mr. Miclot was the President and Vice Chairman and Director of WishBone Medical, Inc., a pediatric orthopedic company dedicated to the unmet needs of children suffering from orthopedic challenges from October 2017 to January 2019. He has been on the Indiana University Alumni Association Advisory Board from October 2016 to October 2021. From October 2015 to January 2018, Mr. Miclot served as President, CEO and Director of Micro Machine Co., a supplier of medical products for the orthopedic and spinal indtries. Prior to joining Micro Machine Co., from May 2013 to September 2014, Mr. Miclot was Executive Vice President of MicroTechnologies, Inc., a medical device supplier. Mr. Miclot was General Manager and Senior Vice President of ArthroCare Corporation from June 2009 to March 2013. From January 2008 to March 2009, Mr. Miclot was President, CEO and Director of Ascension Orthopedics, Inc. He was Vice President of Marketing for the orthopedic global biness unit at Orthofix, Inc. from April 2007 to January 2008, and from March 1994 to April 2007, he served as Senior Vice President with Symmetry Medical Inc., a medical device supplier and was also the Investor Relations Officer, after the NYSE IPO in December 2004 until April 2007. Mr. Miclot has a BA degree in Speech and Hearing and an MA degree in Audiology from Indiana University and an MBA from the Lake Forest Graduate School of Management. - Andrew J. Miclot于2016年3月2日被任命为Precision Optics Corporation, Inc.董事会成员。Miclot先生拥有超过35年的医疗设备供应商领导经验，并为Precision Optics Corporation, Inc.公司带来了丰富的全球行业知识。从2020年9月到2021年5月，Miclot先生担任Electromedical Products International，Inc.的总裁，该公司是一家治疗焦虑、失眠、抑郁和疼痛的医疗设备公司。Miclot先生于2017年10月至2019年1月担任WishBone Medical，Inc.的总裁兼副董事长兼董事，该公司是一家儿科骨科公司，致力于满足患有骨科疾病的儿童未满足的需求。他于2016年10月至2021年10月担任印第安纳大学校友会顾问委员会成员。2015年10月至2018年1月，Miclot先生担任Micro Machine Co.的总裁、首席执行官和董事，该公司是一家为骨科和脊柱行业提供医疗产品的供应商。在2013年5月至2014年9月加入Micro Machine公司之前，Miclot先生是医疗设备供应商MicroTechnologies公司的执行副总裁。Miclot先生于2009年6月至2013年3月担任ArtroCare公司总经理兼高级副总裁。2008年1月至2009年3月，Miclot先生担任Ascension Orthopedics，Inc.总裁、首席执行官和董事。2007年4月至2008年1月，他担任Orthofix，Inc.骨科全球业务部门的营销副总裁。1994年3月至2007年4月，他担任医疗设备供应商Symmetry医疗的高级副总裁，并在2004年12月至2007年4月纽约证券交易所上市后担任投资者关系官。Miclot先生拥有印第安纳大学的语音和听力学士学位和听力学硕士学位，以及1991年获得的Lake Forest管理研究生院的MBA学位。
- Andrew J. Miclot has more than 35 years of leadership experience with medical device suppliers. From September 2020 to May 2021, Mr. Miclot was President of Electromedical Products International, Inc., a medical device company treating anxiety, insomnia, depression and pain. Mr. Miclot was the President and Vice Chairman and Director of WishBone Medical, Inc., a pediatric orthopedic company dedicated to the unmet needs of children suffering from orthopedic challenges from October 2017 to January 2019. He has been on the Indiana University Alumni Association Advisory Board from October 2016 to October 2021. From October 2015 to January 2018, Mr. Miclot served as President, CEO and Director of Micro Machine Co., a supplier of medical products for the orthopedic and spinal indtries. Prior to joining Micro Machine Co., from May 2013 to September 2014, Mr. Miclot was Executive Vice President of MicroTechnologies, Inc., a medical device supplier. Mr. Miclot was General Manager and Senior Vice President of ArthroCare Corporation from June 2009 to March 2013. From January 2008 to March 2009, Mr. Miclot was President, CEO and Director of Ascension Orthopedics, Inc. He was Vice President of Marketing for the orthopedic global biness unit at Orthofix, Inc. from April 2007 to January 2008, and from March 1994 to April 2007, he served as Senior Vice President with Symmetry Medical Inc., a medical device supplier and was also the Investor Relations Officer, after the NYSE IPO in December 2004 until April 2007. Mr. Miclot has a BA degree in Speech and Hearing and an MA degree in Audiology from Indiana University and an MBA from the Lake Forest Graduate School of Management.
- Joseph N. Forkey
-
Joseph N. Forkey，自2011年2月8日起担任Precision Optics Corporation, Inc.首席执行官、总裁兼财务主管。福基博士自2006年以来一直是Precision Optics Corporation, Inc.董事会成员。2011年2月至2014年7月任Precision Optics Corporation, Inc.Precision Optics Corporation, Inc.董事会主席。2006年4月至2011年2月担任Precision Optics Corporation, Inc.执行副总裁兼首席科学官，2003年9月至2006年4月担任Precision Optics Corporation, Inc.首席科学家。自加入Precision Optics Corporation, Inc.以来，他一直参与Precision Optics Corporation, Inc.公司的一般技术和管理活动，并调查利用Precision Optics公司新开发技术的机会。Forkey博士拥有康奈尔大学数学和物理学学士学位，以及普林斯顿大学机械和航空航天工程博士学位。在加入Precision Optics Corporation, Inc.之前，Forkey博士在宾夕法尼亚大学医学院做了七年博士后研究员和研究人员。Forkey博士是Precision Optics Corporation, Inc.董事会的重要成员，因为他在Precision Optics公司行业的科学、运营、战略、交易和高级管理经验丰富。
Joseph N. Forkey has been a member of Board of Directors since 2006. He served as Chairman of Board of Directors from February 2011 to July 2014. He served as Executive Vice President and Chief Scientific Officer from April 2006 to February 2011 and held the position of Chief Scientist from September 2003 to April 2006. Since joining , he has been involved in general technical and management activities of Company, as ll as investigations of opportunities that leverage newly developed technologies. Dr. Forkey holds B.A. degrees in Mathematics and Physics from Cornell University, and a Ph.D. in Mechanical and Aerospace Engineering from Princeton University. Prior to joining , Dr. Forkey spent seven years at the University of Pennsylvania Medical School as a postdoctoral fellow and research staff member. Dr. Forkey is a valuable member of Board due to his depth of scientific, operating, strategic, transactional, and senior management experience in industry. Additionally, Dr. Forkey has held positions of increasing responsibility at Company and holds an intimate knowledge of Company due to his longevity in the industry and with . - Joseph N. Forkey，自2011年2月8日起担任Precision Optics Corporation, Inc.首席执行官、总裁兼财务主管。福基博士自2006年以来一直是Precision Optics Corporation, Inc.董事会成员。2011年2月至2014年7月任Precision Optics Corporation, Inc.Precision Optics Corporation, Inc.董事会主席。2006年4月至2011年2月担任Precision Optics Corporation, Inc.执行副总裁兼首席科学官，2003年9月至2006年4月担任Precision Optics Corporation, Inc.首席科学家。自加入Precision Optics Corporation, Inc.以来，他一直参与Precision Optics Corporation, Inc.公司的一般技术和管理活动，并调查利用Precision Optics公司新开发技术的机会。Forkey博士拥有康奈尔大学数学和物理学学士学位，以及普林斯顿大学机械和航空航天工程博士学位。在加入Precision Optics Corporation, Inc.之前，Forkey博士在宾夕法尼亚大学医学院做了七年博士后研究员和研究人员。Forkey博士是Precision Optics Corporation, Inc.董事会的重要成员，因为他在Precision Optics公司行业的科学、运营、战略、交易和高级管理经验丰富。
- Joseph N. Forkey has been a member of Board of Directors since 2006. He served as Chairman of Board of Directors from February 2011 to July 2014. He served as Executive Vice President and Chief Scientific Officer from April 2006 to February 2011 and held the position of Chief Scientist from September 2003 to April 2006. Since joining , he has been involved in general technical and management activities of Company, as ll as investigations of opportunities that leverage newly developed technologies. Dr. Forkey holds B.A. degrees in Mathematics and Physics from Cornell University, and a Ph.D. in Mechanical and Aerospace Engineering from Princeton University. Prior to joining , Dr. Forkey spent seven years at the University of Pennsylvania Medical School as a postdoctoral fellow and research staff member. Dr. Forkey is a valuable member of Board due to his depth of scientific, operating, strategic, transactional, and senior management experience in industry. Additionally, Dr. Forkey has held positions of increasing responsibility at Company and holds an intimate knowledge of Company due to his longevity in the industry and with .
- Buell G. Duncan
-
Buell G. Duncan于2025年2月28日，董事会任命Buell G. Duncan填补因Richard B. Miles博士退休而产生的董事会空缺。自2022年以来，Duncan先生担任Iron Gate Capital的投资组合顾问和有限合伙人，Iron Gate Capital是一家专注于早期成长型B2B技术公司的风险投资公司，Share Mobility and Respondology的董事会观察员，以及Geminos AI、Demand Spring和Pillir Software的战略顾问。从1992年到2020年，Duncan先生在IBM的多个全球BINES部门担任多个高级领导职务，从2017年4月到2020年12月担任首席营销官、IBM云、数据和AI BINES。邓肯先生带来了数十年的行政领导和战略专长，进一步加强了公司对创新和增长的承诺。
Buell G. Duncan has served as a Portfolio Advisor and Limited Partner for Iron Gate Capital, a venture capital firm foced on early growth B2B technology companies, a board observer of Share Mobility and Respondology, and a strategic advisor to Geminos AI, Demand Spring and Pillir Software. From 1992 through 2020, Mr. Duncan held vario senior leadership positions at a number of IBM's global biness units serving as Chief Marketing Officer, IBM Cloud, Data and AI binesses from April 2017 until December 2020. - Buell G. Duncan于2025年2月28日，董事会任命Buell G. Duncan填补因Richard B. Miles博士退休而产生的董事会空缺。自2022年以来，Duncan先生担任Iron Gate Capital的投资组合顾问和有限合伙人，Iron Gate Capital是一家专注于早期成长型B2B技术公司的风险投资公司，Share Mobility and Respondology的董事会观察员，以及Geminos AI、Demand Spring和Pillir Software的战略顾问。从1992年到2020年，Duncan先生在IBM的多个全球BINES部门担任多个高级领导职务，从2017年4月到2020年12月担任首席营销官、IBM云、数据和AI BINES。邓肯先生带来了数十年的行政领导和战略专长，进一步加强了公司对创新和增长的承诺。
- Buell G. Duncan has served as a Portfolio Advisor and Limited Partner for Iron Gate Capital, a venture capital firm foced on early growth B2B technology companies, a board observer of Share Mobility and Respondology, and a strategic advisor to Geminos AI, Demand Spring and Pillir Software. From 1992 through 2020, Mr. Duncan held vario senior leadership positions at a number of IBM's global biness units serving as Chief Marketing Officer, IBM Cloud, Data and AI binesses from April 2017 until December 2020.
- Joseph P. Pellegrino, Jr.
-
Joseph P. Pellegrino, Jr.，从2003年到2004年，他担任Affordable Luxuries公司（Affordable Luxuries公司是一个直接营销公司。2005年1月，根据美国破产法第七章该公司在马萨诸塞州的美国破产法院自愿申请清算。）的临时首席执行官。从1997年到2003年他在Zoots公司（Zoots公司是一个消费者服务公司由Staples的创办人创办。）任职。最近他担任高级副总裁负责运营。之前，他创建并转售一个地区性购物商场式专业零售公司。他还曾担任雷曼兄弟（Lehman Brothers）合并和收购集团的投资银行分析师。他获得一封哈佛大学（Harvard College）经济学学士学位和哈佛商学院（Harvard Business School）的工商管理硕士学位。
Joseph P. Pellegrino, Jr. served as Lemaitre Vascular, Inc. Chief Financial Officer from July 2007 to March 2025 and has served as a member of Lemaitre Vascular, Inc. Board of Directors since October 2016. Mr. Pellegrino joined Lemaitre Vascular, Inc. as Executive Vice President, Finance, in 2005. From 1997 to 2003, Mr. Pellegrino worked at Zoots, Inc., a consumer services company founded by the founders of Staples, Inc., where most recently he served as senior vice president of operations. Previously, Mr. Pellegrino built and sold a regional mall based specialty retailing company. Mr. Pellegrino has also served as an investment banking analyst at Lehman Brothers as part of their mergers and acquisitions group. Mr. Pellegrino became a director of Precision Optics Corporation, Inc., a designer and manufacturer of advanced optical instruments for the medical, defense, and aerospace industries, in 2025 and chairs their audit committee. Mr. Pellegrino received a Bachelor of Arts in Economics from Harvard College and a Master of Business Administration from the Harvard Business School. - Joseph P. Pellegrino, Jr.，从2003年到2004年，他担任Affordable Luxuries公司（Affordable Luxuries公司是一个直接营销公司。2005年1月，根据美国破产法第七章该公司在马萨诸塞州的美国破产法院自愿申请清算。）的临时首席执行官。从1997年到2003年他在Zoots公司（Zoots公司是一个消费者服务公司由Staples的创办人创办。）任职。最近他担任高级副总裁负责运营。之前，他创建并转售一个地区性购物商场式专业零售公司。他还曾担任雷曼兄弟（Lehman Brothers）合并和收购集团的投资银行分析师。他获得一封哈佛大学（Harvard College）经济学学士学位和哈佛商学院（Harvard Business School）的工商管理硕士学位。
- Joseph P. Pellegrino, Jr. served as Lemaitre Vascular, Inc. Chief Financial Officer from July 2007 to March 2025 and has served as a member of Lemaitre Vascular, Inc. Board of Directors since October 2016. Mr. Pellegrino joined Lemaitre Vascular, Inc. as Executive Vice President, Finance, in 2005. From 1997 to 2003, Mr. Pellegrino worked at Zoots, Inc., a consumer services company founded by the founders of Staples, Inc., where most recently he served as senior vice president of operations. Previously, Mr. Pellegrino built and sold a regional mall based specialty retailing company. Mr. Pellegrino has also served as an investment banking analyst at Lehman Brothers as part of their mergers and acquisitions group. Mr. Pellegrino became a director of Precision Optics Corporation, Inc., a designer and manufacturer of advanced optical instruments for the medical, defense, and aerospace industries, in 2025 and chairs their audit committee. Mr. Pellegrino received a Bachelor of Arts in Economics from Harvard College and a Master of Business Administration from the Harvard Business School.
- Peter H. Woodward
-
Peter H. Woodward，被任命为Precision Optics Corporation， Inc.自2014年7月9日起担任董事会主席，并担任与Precision Optics Corporation， Inc.于2014年7月签订的买卖协议有关的董事会主席。他是MHW资本管理有限责任公司（MHW Capital Management， LLC）的创始人，自2005年9月以来一直担任该职位。MHW专门从事上市公司的大型股权投资，实施运营战略，显著提高其盈利能力。从1996年到2005年，他担任Regan Fund Management， LLC的董事总经理。他曾担任Cartesian， Inc.的总裁兼首席执行官兼董事（2015年6月至2018年7月），目前担任TSS， Inc.的董事会主席和审计委员会主席，以及Innovative Power的首席执行官。他持有科尔盖特大学的经济学学士学位和哥伦比亚大学的国际事务硕士学位，主修国际经济和金融。他也是一名特许金融分析师。
Peter H. Woodward was appointed to Board effective July 9, 2014 and as chairman of the Board in connection with the sale and purchase agreement entered into in July 2014. Mr. Woodward is the founder of MHW Capital Management, LLC, or MHW, a position he has held since September 2005. MHW specializes in large equity investments in public companies implementing operating strategies to significantly improve their profitability. From 1996 to 2005, Mr. Woodward was the Managing Director for Regan Fund Management, LLC. He served as the President and Chief Executive Officer and Director of Cartesian, Inc. from June 2015 to July 2018 and currently serves as Chairman of the Board and Chairman of the Audit Committee for TSS, Inc., and as the CEO of Innovative Por, LLC. Mr. Woodward holds a BA in economics from Colgate University and a Masters of International Affairs with a concentration in international economics and finance from Columbia University. He is also a Chartered Financial Analyst. - Peter H. Woodward，被任命为Precision Optics Corporation， Inc.自2014年7月9日起担任董事会主席，并担任与Precision Optics Corporation， Inc.于2014年7月签订的买卖协议有关的董事会主席。他是MHW资本管理有限责任公司（MHW Capital Management， LLC）的创始人，自2005年9月以来一直担任该职位。MHW专门从事上市公司的大型股权投资，实施运营战略，显著提高其盈利能力。从1996年到2005年，他担任Regan Fund Management， LLC的董事总经理。他曾担任Cartesian， Inc.的总裁兼首席执行官兼董事（2015年6月至2018年7月），目前担任TSS， Inc.的董事会主席和审计委员会主席，以及Innovative Power的首席执行官。他持有科尔盖特大学的经济学学士学位和哥伦比亚大学的国际事务硕士学位，主修国际经济和金融。他也是一名特许金融分析师。
- Peter H. Woodward was appointed to Board effective July 9, 2014 and as chairman of the Board in connection with the sale and purchase agreement entered into in July 2014. Mr. Woodward is the founder of MHW Capital Management, LLC, or MHW, a position he has held since September 2005. MHW specializes in large equity investments in public companies implementing operating strategies to significantly improve their profitability. From 1996 to 2005, Mr. Woodward was the Managing Director for Regan Fund Management, LLC. He served as the President and Chief Executive Officer and Director of Cartesian, Inc. from June 2015 to July 2018 and currently serves as Chairman of the Board and Chairman of the Audit Committee for TSS, Inc., and as the CEO of Innovative Por, LLC. Mr. Woodward holds a BA in economics from Colgate University and a Masters of International Affairs with a concentration in international economics and finance from Columbia University. He is also a Chartered Financial Analyst.
高管简历
中英对照 | 中文 | 英文- Wayne M. Coll
WayneM.Coll自2019年7月15日起担任公司首席财务官，司库兼首席会计和财务官。科尔先生于2018年10月至2019年5月担任私人医疗设备制造商Keystone Dental，Inc.的首席财务官。从2013年10月至2018年9月，科尔先生担任Modern Dental Laboratory，USA LLC的首席财务官兼运营官，该公司是医疗器械制造商，也是香港交易所上市的Modern Dental Group Limited的北美部门:3600。Coll先生从2011年11月开始担任PluroMed，Inc.的首席财务官，该公司是一家医疗设备制造商，被健赞公司收购，他在该公司一直任职到2013年9月。从1990年10月到2011年5月，Coll先生担任多个高级财务管理职位，包括National Dentex Corporation（纳斯达克市场代码:NADX）的首席财务官。
Wayne M. Coll has over 30 years of senior financial executive experience, primarily with medical device based binesses. He formerly served as Chief Financial Officer for Flowonix Medical Incorporated (July 2021 June 2023), Micron Products, Inc. (July 2019 – July 2021), Keystone Dental, Inc. (September 2018 – May 2019), Modern Dental Laboratory A, LLC (September 2013 – September 2018) and National Dentex Corporation (2007 2011). Mr. Coll received a B.S. in Biness Administration and Accounting from the University of Loll, and an M.B.A. from the University of Massachetts Loll.- WayneM.Coll自2019年7月15日起担任公司首席财务官，司库兼首席会计和财务官。科尔先生于2018年10月至2019年5月担任私人医疗设备制造商Keystone Dental，Inc.的首席财务官。从2013年10月至2018年9月，科尔先生担任Modern Dental Laboratory，USA LLC的首席财务官兼运营官，该公司是医疗器械制造商，也是香港交易所上市的Modern Dental Group Limited的北美部门:3600。Coll先生从2011年11月开始担任PluroMed，Inc.的首席财务官，该公司是一家医疗设备制造商，被健赞公司收购，他在该公司一直任职到2013年9月。从1990年10月到2011年5月，Coll先生担任多个高级财务管理职位，包括National Dentex Corporation（纳斯达克市场代码:NADX）的首席财务官。
- Wayne M. Coll has over 30 years of senior financial executive experience, primarily with medical device based binesses. He formerly served as Chief Financial Officer for Flowonix Medical Incorporated (July 2021 June 2023), Micron Products, Inc. (July 2019 – July 2021), Keystone Dental, Inc. (September 2018 – May 2019), Modern Dental Laboratory A, LLC (September 2013 – September 2018) and National Dentex Corporation (2007 2011). Mr. Coll received a B.S. in Biness Administration and Accounting from the University of Loll, and an M.B.A. from the University of Massachetts Loll.
- Joseph N. Forkey
Joseph N. Forkey，自2011年2月8日起担任Precision Optics Corporation, Inc.首席执行官、总裁兼财务主管。福基博士自2006年以来一直是Precision Optics Corporation, Inc.董事会成员。2011年2月至2014年7月任Precision Optics Corporation, Inc.Precision Optics Corporation, Inc.董事会主席。2006年4月至2011年2月担任Precision Optics Corporation, Inc.执行副总裁兼首席科学官，2003年9月至2006年4月担任Precision Optics Corporation, Inc.首席科学家。自加入Precision Optics Corporation, Inc.以来，他一直参与Precision Optics Corporation, Inc.公司的一般技术和管理活动，并调查利用Precision Optics公司新开发技术的机会。Forkey博士拥有康奈尔大学数学和物理学学士学位，以及普林斯顿大学机械和航空航天工程博士学位。在加入Precision Optics Corporation, Inc.之前，Forkey博士在宾夕法尼亚大学医学院做了七年博士后研究员和研究人员。Forkey博士是Precision Optics Corporation, Inc.董事会的重要成员，因为他在Precision Optics公司行业的科学、运营、战略、交易和高级管理经验丰富。
Joseph N. Forkey has been a member of Board of Directors since 2006. He served as Chairman of Board of Directors from February 2011 to July 2014. He served as Executive Vice President and Chief Scientific Officer from April 2006 to February 2011 and held the position of Chief Scientist from September 2003 to April 2006. Since joining , he has been involved in general technical and management activities of Company, as ll as investigations of opportunities that leverage newly developed technologies. Dr. Forkey holds B.A. degrees in Mathematics and Physics from Cornell University, and a Ph.D. in Mechanical and Aerospace Engineering from Princeton University. Prior to joining , Dr. Forkey spent seven years at the University of Pennsylvania Medical School as a postdoctoral fellow and research staff member. Dr. Forkey is a valuable member of Board due to his depth of scientific, operating, strategic, transactional, and senior management experience in industry. Additionally, Dr. Forkey has held positions of increasing responsibility at Company and holds an intimate knowledge of Company due to his longevity in the industry and with .- Joseph N. Forkey，自2011年2月8日起担任Precision Optics Corporation, Inc.首席执行官、总裁兼财务主管。福基博士自2006年以来一直是Precision Optics Corporation, Inc.董事会成员。2011年2月至2014年7月任Precision Optics Corporation, Inc.Precision Optics Corporation, Inc.董事会主席。2006年4月至2011年2月担任Precision Optics Corporation, Inc.执行副总裁兼首席科学官，2003年9月至2006年4月担任Precision Optics Corporation, Inc.首席科学家。自加入Precision Optics Corporation, Inc.以来，他一直参与Precision Optics Corporation, Inc.公司的一般技术和管理活动，并调查利用Precision Optics公司新开发技术的机会。Forkey博士拥有康奈尔大学数学和物理学学士学位，以及普林斯顿大学机械和航空航天工程博士学位。在加入Precision Optics Corporation, Inc.之前，Forkey博士在宾夕法尼亚大学医学院做了七年博士后研究员和研究人员。Forkey博士是Precision Optics Corporation, Inc.董事会的重要成员，因为他在Precision Optics公司行业的科学、运营、战略、交易和高级管理经验丰富。
- Joseph N. Forkey has been a member of Board of Directors since 2006. He served as Chairman of Board of Directors from February 2011 to July 2014. He served as Executive Vice President and Chief Scientific Officer from April 2006 to February 2011 and held the position of Chief Scientist from September 2003 to April 2006. Since joining , he has been involved in general technical and management activities of Company, as ll as investigations of opportunities that leverage newly developed technologies. Dr. Forkey holds B.A. degrees in Mathematics and Physics from Cornell University, and a Ph.D. in Mechanical and Aerospace Engineering from Princeton University. Prior to joining , Dr. Forkey spent seven years at the University of Pennsylvania Medical School as a postdoctoral fellow and research staff member. Dr. Forkey is a valuable member of Board due to his depth of scientific, operating, strategic, transactional, and senior management experience in industry. Additionally, Dr. Forkey has held positions of increasing responsibility at Company and holds an intimate knowledge of Company due to his longevity in the industry and with .
- Joseph Traut
Joseph Traut曾担任T2 Biosystems运营副总裁（20232025）、Lumira DX技术转让副总裁（20212022）和Ximedica（现为Veranex；20172021）制造解决方案副总裁，在2017年之前的其他职位是制造工程、管理和领导。Traut先生拥有马萨诸塞州沃尔瑟姆市本特利学院BINCE Administration、技术管理硕士学位和马萨诸塞州波士顿东北大学机械工程技术理学学士学位。
Joseph Traut was the VP of Operations for T2 Biosystems (2023 2025), VP of Technology Transfer at Lumira Dx (2021 2022) and VP of Manufacturing Solutions at Ximedica (now Veranex; 2017 2021), with additional positions prior to 2017 in manufacturing engineering, management and leadership. Mr. Traut has a Master of Biness Administration, Management of Technology from Bentley College, Waltham, MA and a Bachelor of Science, Mechanical Engineering Technology from Northeastern University, Boston, MA.- Joseph Traut曾担任T2 Biosystems运营副总裁（20232025）、Lumira DX技术转让副总裁（20212022）和Ximedica（现为Veranex；20172021）制造解决方案副总裁，在2017年之前的其他职位是制造工程、管理和领导。Traut先生拥有马萨诸塞州沃尔瑟姆市本特利学院BINCE Administration、技术管理硕士学位和马萨诸塞州波士顿东北大学机械工程技术理学学士学位。
- Joseph Traut was the VP of Operations for T2 Biosystems (2023 2025), VP of Technology Transfer at Lumira Dx (2021 2022) and VP of Manufacturing Solutions at Ximedica (now Veranex; 2017 2021), with additional positions prior to 2017 in manufacturing engineering, management and leadership. Mr. Traut has a Master of Biness Administration, Management of Technology from Bentley College, Waltham, MA and a Bachelor of Science, Mechanical Engineering Technology from Northeastern University, Boston, MA.